Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance.
Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Kuzuya H; Japan Diabetes Prevention Program (JDPP) Research Group. Sakane N, et al. Among authors: tsuzaki k. BMC Public Health. 2011 Jan 17;11(1):40. doi: 10.1186/1471-2458-11-40. BMC Public Health. 2011. PMID: 21235825 Free PMC article. Clinical Trial.
Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment.
Sakane N, Kotani K, Takahashi K, Sano Y, Tsuzaki K, Okazaki K, Sato J, Suzuki S, Morita S, Izumi K, Kato M, Ishizuka N, Noda M, Kuzuya H. Sakane N, et al. Among authors: tsuzaki k. BMC Public Health. 2013 Jan 29;13:81. doi: 10.1186/1471-2458-13-81. BMC Public Health. 2013. PMID: 23356246 Free PMC article. Clinical Trial.
Effects of lifestyle intervention on weight and metabolic parameters in patients with impaired glucose tolerance related to beta-3 adrenergic receptor gene polymorphism Trp64Arg(C/T): Results from the Japan Diabetes Prevention Program.
Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Tsuzaki K, Takahashi K, Kuzuya H; Japan Diabetes Prevention Program (JDPP) Research Group. Sakane N, et al. Among authors: tsuzaki k. J Diabetes Investig. 2016 May;7(3):338-42. doi: 10.1111/jdi.12426. Epub 2015 Oct 29. J Diabetes Investig. 2016. PMID: 27330719 Free PMC article.
172 results